1. Directional Microphones Pick Up Your Voice
2. Answer or End Calls with a Simple Press of the Button
The Naída CI Connect is available now for ordering in the United States. This small boot slides onto the bottom of the Powercel 170 battery, and enables direct Bluetooth streaming from nearly all Bluetooth 4.2 devices and older phones. With the Naída CI Connect, you can hear the phone ring in your processor, and answer the phone by pressing the button on the bottom. There is no need to take the phone out – the microphones on the Naída CI Connect become your phone microphones. Truly hands-free calling with any phone!
You can also use the Naída CI Connect to stream sound from a Bluetooth device directly. And with the TV Connector, you can stream sound to both processors if you have two Naída CI Connects. You can get a Naída CI Connect and a TV Connector for $409 from Advanced Bionics today!
Advanced Bionics announces US availability of the Chorus processor for C1.0 and C1.2 recipients. Chorus offers several great features for recipients of these legacy implants, including:
- All-day hearing on one rechargeable battery
- Significantly smaller than the Platinum Sound Processor
- Roger technology integrated in the processor
- Comes with your choice or Roger Pen or Roger Select
- Waterproof wearing options
Learn more at Advanced Bionics!
Canada Health has approved the SONNET 2 and SONNET 2 EAS processors for MED-EL. Stay tuned for more information as it becomes available!
Cochlear Limited today announced the next phase in its long-term research and development program towards a totally implantable cochlear implant, with the start of a further clinical feasibility study. The development of totally implantable cochlear implant technology is complex, and a commercially available product is not expected for years; however, it remains a long-term development goal for Cochlear.
Editor’s note: Clinical trials provide no guarantee that a product will be available in a given time frame, or even at all. If you are considering a cochlear implant and have questions about potential future developments, please discuss them with your hearing professional.
The Nucleus® 7 sound processor is now available for recipients with CI24M and CI24R implants. Ask your audiologist for details!
MED-EL announced today the US Food and Drug Administration (FDA) approval of the RONDO 2 cochlear implant audio processor. Just place the RONDO 2 on the charge pad and it will charge automatically without wires or cables. The rechargeable battery provides up to 18 hours of battery life, and recharges after four hours.
Product availability is estimated in Fall 2018. For more information, read the press release here.
MED-EL is offering new US recipients a voucher for a free RONDO 2, which can be exchanged for the processor when it becomes available, estimated Fall 2018.
The US FDA has approved the FLEXSOFT array, which has been available in other markets, for sale in the United States.
This array is the same length as the CLASSIC series, but designed to be atraumatic.
Advanced Bionics announces the availability of the Naída CI Q90 Acoustic Earhook for Naída CI Q90 recipients in the US and Canada. With the simple addition of the acoustic earhook, the Naída CI Q90 sound processor can deliver acoustic amplification in combination with electrical stimulation to help maximize your hearing experience. Intended for CI candidates and recipients who may benefit from acoustic amplification, the Naída CI Q90 Acoustic Earhook is an all-in-one solution that extends AB’s portfolio for individuals with severe-to-profound hearing loss.
Read more here.
Advanced Bionics announces approval in the US and Canada for the Naída CI Q90 Acoustic Earhook. The Acoustic Earhook can be added to a Naída CI Q90 processor to provide additional low-frequency information. If residual hearing decreases to the point where the acoustic information is no longer useful, the Acoustic Earhook can be swapped out for Advanced Bionics T-mic.
The Naída CI Q90 Acoustic Earhook will be made available to a limited number of North American centers in 2017 and will be made generally available in the United States and Canada in January 2018.